Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Lotte to acquire Bristol Myers Squibb plant in New York State

by Rick Mullin
May 20, 2022 | A version of this story appeared in Volume 100, Issue 18

 

Lotte will acquire Bristol Myers Squibb’s facility in East Syracuse, New York, for $160 million. Lotte will use the site to establish a North American center for its biologics contract development and manufacturing service. Lotte plans to retain the site’s workforce and continue making products for BMS. The South Korean conglomerate has stated that it intends to invest $1.9 billion in its biologics business over the next 10 years.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.